Banco Santander S.A. grew its position in Oracle Corporation (NYSE:ORCL - Free Report) by 118.8% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 253,482 shares of the enterprise software provider's stock after buying an additional 137,625 shares during the period. Banco Santander S.A.'s holdings in Oracle were worth $35,439,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently made changes to their positions in ORCL. GAMMA Investing LLC increased its stake in shares of Oracle by 15,012.3% in the 1st quarter. GAMMA Investing LLC now owns 4,755,096 shares of the enterprise software provider's stock valued at $664,810,000 after buying an additional 4,723,631 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of Oracle by 20.5% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 13,825,360 shares of the enterprise software provider's stock worth $2,303,858,000 after purchasing an additional 2,350,448 shares during the last quarter. Kovitz Investment Group Partners LLC boosted its position in shares of Oracle by 268.4% in the 4th quarter. Kovitz Investment Group Partners LLC now owns 3,077,947 shares of the enterprise software provider's stock worth $512,909,000 after purchasing an additional 2,242,520 shares during the last quarter. Northern Trust Corp boosted its position in shares of Oracle by 12.5% in the 4th quarter. Northern Trust Corp now owns 19,620,534 shares of the enterprise software provider's stock worth $3,269,566,000 after purchasing an additional 2,176,892 shares during the last quarter. Finally, Universal Beteiligungs und Servicegesellschaft mbH bought a new position in shares of Oracle in the 4th quarter worth $216,047,000. 42.44% of the stock is owned by institutional investors and hedge funds.
Oracle Price Performance
Oracle stock opened at $244.44 on Friday. Oracle Corporation has a 12 month low of $118.86 and a 12 month high of $260.87. The stock's 50 day moving average is $213.55 and its 200-day moving average is $174.74. The company has a current ratio of 0.75, a quick ratio of 0.75 and a debt-to-equity ratio of 4.07. The company has a market capitalization of $686.59 billion, a price-to-earnings ratio of 56.32, a PEG ratio of 3.79 and a beta of 1.43.
Oracle (NYSE:ORCL - Get Free Report) last posted its earnings results on Wednesday, June 11th. The enterprise software provider reported $1.70 EPS for the quarter, beating the consensus estimate of $1.64 by $0.06. Oracle had a return on equity of 87.34% and a net margin of 21.68%. The company had revenue of $15.90 billion for the quarter, compared to the consensus estimate of $15.58 billion. During the same quarter in the prior year, the business earned $1.63 earnings per share. The firm's revenue for the quarter was up 11.3% on a year-over-year basis. Equities research analysts expect that Oracle Corporation will post 5 EPS for the current year.
Oracle Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Thursday, July 24th. Investors of record on Thursday, July 10th were paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 0.8%. The ex-dividend date was Thursday, July 10th. Oracle's payout ratio is 46.08%.
Wall Street Analyst Weigh In
Several research analysts have recently issued reports on the company. Westpark Capital raised their price target on Oracle from $195.00 to $246.00 and gave the stock a "buy" rating in a research report on Thursday, June 12th. Loop Capital set a $135.00 price target on Oracle in a research report on Tuesday, June 10th. BMO Capital Markets raised their price target on Oracle from $235.00 to $245.00 and gave the stock an "outperform" rating in a research report on Wednesday, July 2nd. Guggenheim lifted their target price on Oracle from $220.00 to $250.00 and gave the stock a "buy" rating in a report on Wednesday, June 18th. Finally, UBS Group lifted their target price on Oracle from $250.00 to $280.00 and gave the stock a "buy" rating in a report on Thursday, July 17th. Nine equities research analysts have rated the stock with a hold rating, twenty-three have issued a buy rating and three have issued a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $218.29.
Check Out Our Latest Report on ORCL
Insiders Place Their Bets
In related news, insider Clayton M. Magouyrk sold 15,000 shares of the business's stock in a transaction that occurred on Tuesday, June 17th. The stock was sold at an average price of $214.10, for a total value of $3,211,500.00. Following the completion of the sale, the insider directly owned 60,722 shares in the company, valued at approximately $13,000,580.20. The trade was a 19.81% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Rona Alison Fairhead purchased 480 shares of the business's stock in a transaction that occurred on Monday, July 7th. The stock was bought at an average price of $233.87 per share, with a total value of $112,257.60. Following the completion of the purchase, the director owned 22,110 shares of the company's stock, valued at $5,170,865.70. This trade represents a 2.22% increase in their position. The disclosure for this purchase can be found here. Insiders sold a total of 431,169 shares of company stock valued at $82,908,609 in the last quarter. Company insiders own 42.20% of the company's stock.
About Oracle
(
Free Report)
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Oracle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.
While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report